A successful and independent Corporation
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.
Boehringer Ingelheim
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.
-
Financial Highlights
Our Company
Net sales, R&D expenditures, Operating Income and Personnel Capacity: All business areas contributed to sales growth in 2017.
-
Scleroderma
In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
-
BI In Reach Africa
Our Company
Boehringer Ingelheim launches the initiative ‘In Reach Africa’ to address key healthcare infrastructure and access priorities across Africa
-
Annual Press Conference 2017
NEWS
Read more about the 2017 financial results presented in our Annual Press Conference.
-
Our Company
For over 130 years, Boehringer Ingelheim has continuously undergone change. Read more how agility drives us in our Annual Report 2017.
-
Annual Report 2017
-
DOWNLOAD PDF (378.74 KB)
Boehringer Ingelheim Corporate FactsheetFind all important information about our company at a glance.
-
Boehringer Ingelheim is a Top Employer
Corporate Profile
Boehringer Ingelheim achieves the “Top Employer” award in eight countries.
-
Our Company
As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of six members. Read more about their respective responsibilities.
-
Careers
We offer a wide range of career development opportunities in over 140 affiliates worldwide. Click "Read more" to check out the local career sites.
-
-
Our Company
Get an overview of the major consolidated companies and our main business areas Human Pharmaceuticals and Animal Health
-
Working at BI - Testimonials
Our Employees
Learn more about what it is like to work for Boehringer Ingelheim in our video.
-
BI Image Video Value through Innovation
Our Company
New company video of Boehringer Ingelheim – Value through Innovation
-
Careers
As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
-
Corporate Citizenship
As a service to society, Boehringer Ingelheim’s research and development focuses on a variety of external partnerships.
-
-
Corporate Citizenship
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
-
Business Partners